Subscribe to RSS
DOI: 10.1055/s-2004-835292
© Georg Thieme Verlag Stuttgart · New York
Bedeutung der arteriellen Hypertonie für Augenerkrankungen
The importance of systemic hypertension for eye diseasesPublication History
eingereicht: 30.8.2004
akzeptiert: 27.10.2004
Publication Date:
09 November 2004 (online)
![](https://www.thieme-connect.de/media/dmw/200446/lookinside/thumbnails/10.1055-s-2004-835292-1.jpg)
Durch die zunehmende Altersentwicklung werden chronische Erkrankungen in den nächsten Jahren bei der Versorgung der Bevölkerung an Bedeutung gewinnen. Dabei werden Erkrankungen des Auges eine maßgebliche Rolle spielen. In einer kürzlich durchgeführten Longitudinalstudie stieg die Häufigkeit in einer Altersgruppe mit durchschnittlich 65 Jahren entweder einer diabetischen Retinopathie, einer altersbedingten Makuladegeneration oder eines Glaukoms im Laufe von 9 Jahren von 13,4 auf 45,4 % [28] an. Diese drei Augenkrankheiten repräsentieren auch in Deutschland die drei häufigsten Erblindungsursachen [27], so dass es wichtig ist, diese Krankheiten frühzeitiger zu diagnostizieren und besser therapeutisch einzustellen. Dabei besitzt die arterielle Hypertonie als „internistische Volkskrankheit” eine herausragende Bedeutung als Risikofaktor für zahlreiche Augenkrankheiten.
Literatur
- 1 Ahmetoglu A, Erdol H, Simsek A, Gokce M, Dinc H, Gumele H R. Effect of hypertension and candesartan on the blood flow velocity of the extraocular vessels in hypertensive patients. Eur J Ultrasound. 2003; 16 177-182
- 2 Alm A, Bill A. Ocular and optic nerve blood flow at normal and increased intraocular pressures in monkeys (Macaca irus): a study with radioactively labelled microspheres including flow determinations in brain and some other tissues. Exp Eye Res. 1973; 15 15-29
- 3 Aoki N, Horibe H, Ohno Y, Hayakawa N, Kondo R. Epidemiological evaluation of fundoscopic findings in cerebrovascular diseases. III. Observer variability and reproducibility for fundoscopic findings. Jpn Circ J. 1977; 41 11-17
- 4 Bill A, Sperber G O. Control of retinal and choroidal blood flow. Eye. 1990; 4 319-325
- 5 Bonomi L, Marchini G, Marraffa M, Bernardi P, Morbio R, Varotto A. Vascular risk factors for primary open angle glaucoma. The Egna-Neumarkt Study. Ophthalmology. 2000; 107 1287-1293
- 6 Buono L M, Foroozan R, Sergott R C, Savino P J. Nonarteritic anterior ischemic optic neuropathy. Curr Opin Ophthalmol. 2002; 13 3357-3361
- 7 Chobanin A. Adaptive and maladaptive responses of the arterial wall to hypertension. Hypertension. 1990; 15 666-674
- 8 Cignarelli M, Luigia de Cicco M, Damato A. et al . High systolic blood presssure increases prevalence and severity of retinopathy in NIDDM patients. Diabetes Care. 1992; 15 1002-1008
- 9 Dzau V Y, Gibbons G H. Vascular remodeling: mechanisms and implications. J Cardiovasc Pharmacol. 1993; 21 1-5 (suppl 1)
- 10 Elman M J, Bhatt A K, Quinlan P M, Enger C. The risk for systemic vascular diseases and mortality in patients with central retinal vein occlusion. Ophthalmology. 1990; 97 1543-1548
- 11 Fuchsjäger-Mayrl G, Wally B, Georgopoulos M. et al . Ocular blood flow and systemic blood pressure in patients with primary open-angle glaucoma and ocular hypertension. Invest Ophthalmol Vis Sci. 2004; 45 834-839
- 12 Greene A, Tonellato P J, Lui J, Lombard J H, Cowley A W. Microvascular rarefication and tissue vascular resistence in hypertension. Am J Physiol. 1989; 243 126-131
- 13 Greite J H. Hypertonie und Arteriosklerose aus ophthalmologischer Sicht. Stuttgart: Enke In: Naumann GOH, Merté HJ, Hollwich F, Gloor B (Hrsg.): Gefässerkrankungen des Auges 1983: 55-70
- 14 Hacioglu G, Agar A, Ozkaya G, Yargicoglu P, Gumuslu S. The effect of different hypertension models on visual evoked potentials. Int J Neurosci. 2002; 112 1321-1335
- 15 Hansen-Smith F, Greene A S, Cowley A W, Lombard J H. Structural changes during microvascular rarefication in chronic hypertension. Hypertension. 1990; 15 922-928
- 16 Hayreh S S, Jonas J B. Appearance of the optic disk and retinal nerve fiber layer in atherosclerosis and arterial hypertension: an experimental study in rhesus monkeys. Am J Ophthalmol. 2000; 130 91-96
- 17 Hayreh S S, Podhajsky P, Zimmerman M B. Role of nocturnal arterial hypotension in optic nerve head ischemic disorders. Ophthalmologica. 1999; 213 76-96
- 18 Hayreh S S, Servaisn G E, Virdi P S. Fundus lesions in malignant hypertension (VI). Hypertensive choroidopathy. Ophthalmology. 1986; 93 1383-1400
- 19 Heidbreder E, Huller U, Schafer B. et al . Severe hypertensive retinopathy: Increased incidence in renoparenchymal hypertension. Am J Nephrol. 1987; 7 394-400
- 20 Hoyer J. Blutdruckabhängige Änderungen der Aktivität retinaler Ganglienzellen. Klin Monatsbl Augenheilkd. 1975; 166 185-189
- 21 Hubbard L D, Brothers R J, King W N, Clegg L X, Klein R, Cooper L S, Sharrett A R, Davis M D, Cai J. Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the atherosclerosis risk in communities study. Ophthalmology. 1999; 106 2269-2280
- 22 Jampol L M. Hypertension and visual outcomes in Macular Photocoagulation Study. Arch Ophthalmol. 1991; 109 1232-1241
- 23 Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure .Sixth Report. NIH publication No 98 - 4080 1997
- 24 Keith N M, Wagener H P, Barker N W. Some different types of essential hypertension: their course and prognosis. Am J Med Sci. 1939; 197 332-343
- 25 Kiel J W. Choroidal myogenic autoregulation and intraocular pressure. Exp Eye Res. 1994; 58 529-543
- 26 Klein R, Klein B E, Moss S E, Cruickshanks K J. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XVII: the 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology. 1998; 105 1801-1815
- 27 Krumpaszky H G, Lüdtke R, Mickler A, Klauss V, Selbmann H K. Blindness incidence in germany. Ophthalmologica. 1999; 213 176-182
- 28 Lee P P, Feldman Z W, Ostermann J, Brown D S, Sloan F A. Longitudinal prevalence of major eye diseases. Arch Ophthalmol. 2003; 212 1303-1310
- 29 Locke L C. Ocular manifestations of hypertension. Optom Clin. 1992; 2 47-76
- 30 Lund O E. Über den Wert retinaler Gefäßveränderungen in der Diagnostik der Arteriosklerose. Basel:Karger 1964
- 31 Lund O E. Fundus hypertonicus. Spiegel der Niere oder des Hirns?. MMW. 1974; 12 613-616
- 32 Mangat H S. Retinal artery occlusion. Surv Ophthalmol. 1995; 40 145-156
- 33 Mc Leod D, Marshall J, Kohner E M. et al . The role of axoplasmic transport in the pathogenesis of retinal cotton-wool spots. Br J Ophthalmol. 1977; 61 177-191
- 34 Nagel E, Vilser W, Lanzl I. Age, blood pressure, and vessel diameter as factors influencing the arterial retinal flicker response. Invest Ophthalmol Vis Sci. 2004; 45 1486-1492
- 35 Pache M, Kube T, Wolf S, Kutschbach P. Do angiographic data support a detailed classification of hypertensive fundus changes?. J Hum Hypertens. 2002; 16 405-410
- 36 Palatini P, Penzo M, Bongiovi S. et al . Role of ophthalmoscopy in arterial hypertension: A problem revisited. Cardiologia. 1991; 36 713-722
- 37 Pillunat L E, Anderson D R, Knighton R W, Joos K M, Feuer W J. Autoregulation of human optic nerve head circulation in response to increased intraocular pressure. Exp Eye Res. 1997; 64 737-744
- 38 Portaluppi F, Boari B, Manfredini R. Oxidative stress in essential hypertension. Curr Pharm Des. 2004; 10 1695-1698
- 39 Rassam S M, Patel V, Kohner E M. The effect of experimental hypertension on retinal vascular autoregulation in humans: a mechanism for the progression of diabetic retinopathy. Exp Physiol. 1995; 80 53-68
- 40 Robinson F, Riva C E, Grunwald J E, Petrig B L, Sinclair S H. Retinal blood flow autoregulation: a response to an acute increase in blood pressure. Invest Ophthalmol. 1986; 27 722-726
- 41 Romero Aroca P, Fernandez Ballart J, Mendez Marin I, Salvat Serra M, Martinez Salcedo I. Study of the relationship between retinal and renal microangiopathy in patients with diabetes mellitus type II. Rev Clin Esp. 2003; 206 268-272
- 42 Rüfer F, Schröder A, Winter R, Erb C. Risikofaktorenanalyse und Therapievergleich zwischen Heparin und Hämodilution bei Zentralarterienverschluss des Auges. Ophthalmologe. 2003; 100 819-824
- 43 Schröder A, Erb C, Falk S, Schwartze G, Radermacher J, Winter R. Farbsinnstörungen bei Patienten mit einer arteriellen Hypertonie. Ophthalmologe. 2002; 99 375-379
- 44 Schröder A, Falk S, Wollstein J, Meyer M, Erb C. Morphologie der Papille bei Patienten mit einer arteriellen Hypertonie. Z prakt Augenheilkd. 2003; 24 376-378
- 45 Schulte K, Wolf S, Koch M J, Arend O, Remky A, Ittel T H, Reim M. Retinale Hämodynamik bei Patienten mit arterieller Hypertonie. Ophthalmologe. 1993; 90 479-485
- 46 Tielsch J M, Katz J, Sommer A, Quigley H A, Javitt J C. Hypertension, perfusion pressure, and primary open-angle glaucoma. Arch Ophthalmol. 1995; 113 216-221
- 47 Tso M OM, Abrams G W, Jampol L M. Hypertensive retinopathy, choroidopathy, and optic neuropathy: A clinical and pathophysiological approach to classification. Baltimore: Williams and Wilkins In: Singerman LJ, Jampol LM, eds. Retinal and choroidal manifestations of systemic disease 1991:7: 9-127
- 48 Van Leeuwen R, Ikram M K, Vingerling J R, Wittemann J C, Hofman A, de Jong P T. Blood pressure, atherosclerosis, and the incidence of age-related maculopathy: the Rotterdam Study. Invest Ophthalmol Vis Sci. 2003; 44 377 137-77
- 49 Wolf S, Arend O, Schulte K, Ittel T H, Reim M. Quantification of retinal capillary density and flow velocity in patients with essential hypertension. Hypertension. 1994; 23 464-467
- 50 Wong T Y, Hubbard L D, Klein R, Marino E K, Kronmal R, Sharrett A R, Siscovick D S, Burke G, Tielsch J M. Retinal microvascular abnormalitis and blood pressure in older people: the Cardiovascular Health Study. Br J Ophthalmol. 2002; 86 1007-1013
- 51 Wong T Y, Klein R, Couper D J. et al . Retinal microvascular abnormalities and incident stroke: The Atherosklerosis Risk in Communities Study. Lancet. 2001; 358 1134-1140
- 52 Wong T Y, Klein R, Sharrett A R. et al . Retinal arteriolar narrowing and risk of coronary heart disease in men and women. The Atherosclerosis Risk in Community Study. J Am Med Assoc . 2002; 287 1153-1159
Priv.-Doz. Dr. Carl Erb
Augenklinik der Medizinische Hochschule Hannover
Carl-Neuberg-Straße 1
30625 Hannover
Phone: 0511/5329232
Fax: 0511/5328232
Email: Erb.Carl@mh-hannover.de